KR102586050B1 - Composition for skin anti-pollution containing banana peel extract as an active ingredient - Google Patents
Composition for skin anti-pollution containing banana peel extract as an active ingredient Download PDFInfo
- Publication number
- KR102586050B1 KR102586050B1 KR1020210092445A KR20210092445A KR102586050B1 KR 102586050 B1 KR102586050 B1 KR 102586050B1 KR 1020210092445 A KR1020210092445 A KR 1020210092445A KR 20210092445 A KR20210092445 A KR 20210092445A KR 102586050 B1 KR102586050 B1 KR 102586050B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- skin
- pollution
- banana peel
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 80
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 235000018290 Musa x paradisiaca Nutrition 0.000 title claims abstract description 42
- 239000004480 active ingredient Substances 0.000 title claims abstract description 15
- 240000005561 Musa balbisiana Species 0.000 title abstract description 40
- 239000000428 dust Substances 0.000 claims abstract description 22
- 230000000694 effects Effects 0.000 claims abstract description 20
- 239000002537 cosmetic Substances 0.000 claims abstract description 11
- 235000013376 functional food Nutrition 0.000 claims abstract description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 41
- 238000000605 extraction Methods 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 102000004127 Cytokines Human genes 0.000 claims description 16
- 108090000695 Cytokines Proteins 0.000 claims description 16
- 230000002757 inflammatory effect Effects 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 13
- 240000000783 Origanum majorana Species 0.000 claims description 10
- 235000011203 Origanum Nutrition 0.000 claims description 9
- 241000234295 Musa Species 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 150000001299 aldehydes Chemical class 0.000 claims description 3
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 claims description 3
- 241000205585 Aquilegia canadensis Species 0.000 claims description 2
- 241001474374 Blennius Species 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract description 10
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 239000003344 environmental pollutant Substances 0.000 abstract description 5
- 231100000719 pollutant Toxicity 0.000 abstract description 5
- 231100001240 inorganic pollutant Toxicity 0.000 abstract description 4
- 206010040880 Skin irritation Diseases 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000036556 skin irritation Effects 0.000 abstract description 3
- 231100000475 skin irritation Toxicity 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 16
- 239000006210 lotion Substances 0.000 description 13
- 239000006071 cream Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 description 8
- 239000000809 air pollutant Substances 0.000 description 8
- 231100001243 air pollutant Toxicity 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 description 7
- 230000028709 inflammatory response Effects 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 6
- 230000003013 cytotoxicity Effects 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 238000002386 leaching Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000003642 reactive oxygen metabolite Substances 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 5
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 5
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 239000000686 essence Substances 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 108010063738 Interleukins Proteins 0.000 description 4
- 102000015696 Interleukins Human genes 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- -1 pack Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 3
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 3
- 241000756137 Hemerocallis Species 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 3
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 3
- 102100028452 Nitric oxide synthase, endothelial Human genes 0.000 description 3
- 102000008233 Toll-Like Receptor 4 Human genes 0.000 description 3
- 108010060804 Toll-Like Receptor 4 Proteins 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 231100001083 no cytotoxicity Toxicity 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 239000013618 particulate matter Substances 0.000 description 3
- 235000015277 pork Nutrition 0.000 description 3
- 230000000770 proinflammatory effect Effects 0.000 description 3
- 235000021067 refined food Nutrition 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 240000005925 Aeschynanthus radicans Species 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000004890 Interleukin-8 Human genes 0.000 description 2
- 108090001007 Interleukin-8 Proteins 0.000 description 2
- 240000000161 Lagerstroemia indica Species 0.000 description 2
- 102000043136 MAP kinase family Human genes 0.000 description 2
- 108091054455 MAP kinase family Proteins 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 244000182807 Mentha suaveolens Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 102100022397 Nitric oxide synthase, brain Human genes 0.000 description 2
- 101710090055 Nitric oxide synthase, endothelial Proteins 0.000 description 2
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 2
- 235000010676 Ocimum basilicum Nutrition 0.000 description 2
- 240000007926 Ocimum gratissimum Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 2
- 108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 235000017715 Thymus pulegioides Nutrition 0.000 description 2
- 240000006001 Thymus serpyllum Species 0.000 description 2
- 235000004054 Thymus serpyllum Nutrition 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000005427 atmospheric aerosol Substances 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 235000020221 chamomile extract Nutrition 0.000 description 2
- 229940119217 chamomile extract Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 239000003245 coal Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 230000016396 cytokine production Effects 0.000 description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000002803 fossil fuel Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 235000020723 lavender extract Nutrition 0.000 description 2
- 229940083980 lavender extract Drugs 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940105902 mint extract Drugs 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000007302 negative regulation of cytokine production Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 230000037368 penetrate the skin Effects 0.000 description 2
- 235000020737 peppermint extract Nutrition 0.000 description 2
- 229940013712 pineapple extract Drugs 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 235000013324 preserved food Nutrition 0.000 description 2
- 235000020991 processed meat Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000020748 rosemary extract Nutrition 0.000 description 2
- 229940092258 rosemary extract Drugs 0.000 description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 2
- 235000020752 sage extract Nutrition 0.000 description 2
- 229940112950 sage extract Drugs 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 229940105022 spearmint extract Drugs 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 102000003390 tumor necrosis factor Human genes 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- 102000005869 Activating Transcription Factors Human genes 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000003984 Aryl Hydrocarbon Receptors Human genes 0.000 description 1
- 108090000448 Aryl Hydrocarbon Receptors Proteins 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 1
- 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000002941 Hemerocallis fulva Nutrition 0.000 description 1
- 240000009206 Hemerocallis fulva Species 0.000 description 1
- 101000725401 Homo sapiens Cytochrome c oxidase subunit 2 Proteins 0.000 description 1
- 101001128158 Homo sapiens Nanos homolog 2 Proteins 0.000 description 1
- 101001128156 Homo sapiens Nanos homolog 3 Proteins 0.000 description 1
- 101001124309 Homo sapiens Nitric oxide synthase, endothelial Proteins 0.000 description 1
- 101001124991 Homo sapiens Nitric oxide synthase, inducible Proteins 0.000 description 1
- 101000605127 Homo sapiens Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 102000019149 MAP kinase activity proteins Human genes 0.000 description 1
- 108040008097 MAP kinase activity proteins Proteins 0.000 description 1
- 238000003222 MTT reduction assay Methods 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 108010008858 Nitric Oxide Synthase Type I Proteins 0.000 description 1
- 101710111444 Nitric oxide synthase, brain Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 235000006297 Origanum majorana Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241001317551 Prunella asiatica Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 102000004495 STAT3 Transcription Factor Human genes 0.000 description 1
- 108010017324 STAT3 Transcription Factor Proteins 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 231100000722 genetic damage Toxicity 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
- 229940096397 interleukin-8 Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002957 persistent organic pollutant Substances 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 108091008023 transcriptional regulators Proteins 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 235000019511 tuna Nutrition 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 바나나 껍질 추출물을 유효 성분으로 포함하는 피부 안티폴루션용 조성물에 관한 것으로, 미세먼지, 유기성 또는 무기성 오염원 등에 대한 피부 항오염 효과를 가져, 오염원에 의한 피부 트러블 등의 문제를 방지하고, 피부 자극을 최소화할 수 있고, 항산화 효과가 우수하다.
또한, 피부 도포성 및 흡수성이 우수하고, 선호도가 높은 화장료 제형으로 이용 가능하고, 기호도 높은 기능성 식품 조성물로 제공될 수 있다.The present invention relates to a composition for skin anti-pollution containing banana peel extract as an active ingredient, and has an anti-pollution effect on the skin against fine dust, organic or inorganic pollutants, etc., preventing problems such as skin troubles caused by pollutants. , It can minimize skin irritation and has excellent antioxidant effects.
In addition, it has excellent skin applicability and absorption, can be used as a cosmetic formulation with high preference, and can be provided as a functional food composition with high preference.
Description
본 발명은 바나나 껍질 추출물을 유효 성분으로 포함하는 피부 안티 폴루션용 조성물에 관한 것이다. The present invention relates to a composition for skin anti-pollution containing banana peel extract as an active ingredient.
피부는 최외층에 있는 최대 조직이며, 자외선, 미생물, 바이러스나 대기 오염 물질과 같은 외적 자극에 노출되어 있다. 자외선에 대해서는 피부에 손상을 줌으로써 피부 노화의 원인이 되고 있음이 오래전부터 연구되어 있다. The skin is the outermost layer and largest tissue and is exposed to external irritants such as ultraviolet rays, microorganisms, viruses, and air pollutants. It has long been studied that ultraviolet rays cause skin aging by damaging the skin.
한편, 근년에는 미립자상 대기 오염 물질의 피부에 대한 부착이 노화와 관련될 가능성에 대하여 보고되는 예가 증가하고 있다. 또한, 담배에 포함되는 벤조피렌이 표피 세포 내에 존재하는 아릴 히드로카본 수용체(Aryl hydrocarbon receptor)를 활성화시켜, 약물 대사 효소인 시토크롬(Cytochrome) P450(CYP1)의 유도를 촉구함과 함께 활성 산소가 산생되어, 인터류킨 8의 산생을 유도하여 염증 반응을 유발하는 것이 보고되어 있다.Meanwhile, in recent years, there has been an increasing number of reported cases regarding the possibility that the adhesion of particulate air pollutants to the skin is related to aging. In addition, benzopyrene contained in cigarettes activates the aryl hydrocarbon receptor present in epidermal cells, prompting the induction of cytochrome P450 (CYP1), a drug metabolizing enzyme, and producing reactive oxygen species. It has been reported that it induces the production of interleukin 8, causing an inflammatory response.
이들 외적 자극으로부터 피부를 보호하기 위해서는, 미립자상 대기 오염 물질 등의 손상의 원인이 될 수 있는 물질을 피부에 부착ㆍ침투시키지 않을 것 및/또는 부착된 자극 원인 물질이 피부 내부에 주는 영향을 완화할 것 등이 고려된다. In order to protect the skin from these external irritants, do not allow substances that can cause damage, such as particulate air pollutants, to adhere to or penetrate the skin and/or alleviate the effects of the attached irritating substances on the inside of the skin. Things to do are taken into consideration.
상술한 바와 같이 피부를 보호하기 위한 방책으로서, 종래에는 피부에 피막을 형성시켜 미립자상 대기 오염 물질을 피부에 부착시키지 않거나 혹은 부착되어도 용이하게 씻어낼 수 있다고 하는 제제의 제안이 있기는 하지만, 피부를 피막으로 피복하기 때문에 사용 감촉이 나쁘고, 또한 모든 자극 원인 물질에 대하여 유효한지의 여부는 불분명하였다.As a measure to protect the skin as described above, there have been proposals in the past for agents that form a film on the skin to prevent particulate air pollutants from adhering to the skin or to allow them to be easily washed off even if they do adhere to the skin. Because it is covered with a film, it feels bad when used, and it is unclear whether it is effective against all substances that cause irritation.
미립자상 대기 오염 물질은 피부에 부착ㆍ침투함으로써 세포에 산화 스트레스를 부여하여 염증 반응이나 세포의 대사, 유전자 손상 등을 야기하는 것이 연구되어 있지만, 세포 손상의 메커니즘은 산화, 염증, 세포의 대사나 유전자 발현의 이상 등 매우 다양하며 아직 미지의 부분이 많고, 그 때문인지 시장에서는 안티폴루션(antipollution) 효과를 갖는 소재는 그다지 많지 않은 것이 현실이다.Studies have shown that particulate air pollutants attach to and penetrate the skin and cause oxidative stress on cells, causing inflammatory reactions, cell metabolism, and genetic damage. However, the mechanisms of cell damage include oxidation, inflammation, cell metabolism, and other factors. There are many diverse and still unknown aspects, such as abnormalities in gene expression, and perhaps for this reason, the reality is that there are not many materials on the market that have antipollution effects.
예를 들어, 보리수나무과 히포파이속의 추출물이 입자상 대기 오염 물질 등의 대기 에어로졸 입자에서 기인하는 PGE2의 상승을 억제함으로써, 대기 에어로졸 입자에서 기인하는 피부 염증을 억제하는 작용을 발견하였다. For example, it was discovered that extracts from the genus Hippophyllaceae have the effect of suppressing skin inflammation caused by atmospheric aerosol particles by suppressing the rise in PGE2 caused by atmospheric aerosol particles such as particulate air pollutants.
또한, 피부 내부에 침투한 오염 물질이 표피 세포에서 피부 염증을 야기하는 메커니즘에 주목하여, 아미노산류의 아연염 및/또는 아연 착체에 의한 세포 상해 완화 작용, CYP1 과잉 유도 작용, COX2 과잉 유도 작용, IL8 과잉 유도 작용의 억제와 같은 유용성을 발견하였다.In addition, attention was paid to the mechanism by which pollutants penetrating inside the skin cause skin inflammation in epidermal cells, and the action of alleviating cell damage by zinc salts and/or zinc complexes of amino acids, excessive induction of CYP1, excessive induction of COX2, etc. It was found to be useful in inhibiting IL8 hyperinduction.
이상과 같은 상황에 더하여 제제의 다양화, 처방 배합 상의 선택지의 확대라는 관점이나, 메커니즘이 다른 미립자상 대기 오염 물질에 대한 안티폴루션제를 사용한 상승 효과라는 관점, 보다 안전하고 높은 유효성을 갖는 안티폴루션제라는 관점에서, 신규 안티폴루션제의 개발이 요구되고 있다.In addition to the above situations, there are perspectives on diversification of preparations and expansion of options in prescription formulations, synergistic effects of using anti-pollution agents against particulate air pollutants with different mechanisms, and anti-inflammatory drugs with safer and higher effectiveness. From the viewpoint of pollution agents, the development of new anti-pollution agents is required.
본 발명의 목적은 바나나 껍질 추출물을 유효 성분으로 포함하는 피부 안티 폴루션용 조성물을 제공하는 것이다. The purpose of the present invention is to provide a composition for skin anti-pollution containing banana peel extract as an active ingredient.
본 발명의 다른 목적은 미세먼지, 유기성 또는 무기성 오염원 등에 대한 피부 항오염 효과를 가져, 오염원에 의한 피부 트러블 등의 문제를 방지하고, 피부 자극을 최소화할 수 있고, 항산화 효과가 우수한 바나나 껍질 추출물을 유효 성분으로 포함하는 피부 안티 폴루션용 조성물을 제공하는 것이다.Another object of the present invention is to provide a banana peel extract that has an anti-pollution effect on the skin against fine dust, organic or inorganic pollutants, etc., can prevent problems such as skin problems caused by pollutants, minimize skin irritation, and has excellent antioxidant effects. To provide a composition for skin anti-pollution containing as an active ingredient.
본 발명의 다른 목적은 피부 도포성 및 흡수성이 우수하고, 선호도가 높은 제형으로 이용 가능한 바나나 껍질 추출물을 유효 성분으로 포함하는 피부 안티 폴루션용 조성물을 제공하는 것이다.Another object of the present invention is to provide a composition for skin anti-pollution containing banana peel extract as an active ingredient, which has excellent skin applicability and absorption and can be used in a highly preferred formulation.
상기 목적을 달성하기 위하여, 본 발명의 일 실시예에 따른 피부 안티폴루션용 조성물은 바나나 껍질 추출물을 유효 성분으로 포함할 수 있다.In order to achieve the above object, the composition for skin anti-pollution according to an embodiment of the present invention may include banana peel extract as an active ingredient.
상기 바나나 껍질 추출물은 물, C1 내지 C6의 저급 알코올 및 이들의 혼합물로 이루어진 군으로부터 선택되는 추출 용매를 이용하여 추출될 수 있다. The banana peel extract may be extracted using an extraction solvent selected from the group consisting of water, C 1 to C 6 lower alcohols, and mixtures thereof.
상기 조성물은 유해 인자로 인해 유도된 NO, PGE2 및 염증성 사이토카인 생성 억제 효과가 우수하다. The composition is excellent in suppressing the production of NO, PGE 2 and inflammatory cytokines induced by harmful factors.
상기 유해 인자는 미세먼지, 다환 방향족 탄화수소, 알데하이드류, 질소산화물류 및 이들의 혼합으로 이루어진 군으로부터 선택될 수 있다. The harmful factors may be selected from the group consisting of fine dust, polycyclic aromatic hydrocarbons, aldehydes, nitrogen oxides, and mixtures thereof.
상기 조성물은 스피아민트 추출물, 애플민트 추출물, 페퍼민트 추출물, 레몬밤 추출물, 스위트 바질 추출물, 골든레몬타임 추출물, 파인애플 추출물, 세이지 추출물, 라벤더 추출물, 로즈마리 추출물, 카모마일 추출물, 마조람 추출물, 넘나물 추출물, 삼잎나물 추출물 및 이들의 혼합으로 이루어진 군으로부터 선택된 천연 추출물을 추가로 포함할 수 있다. The composition includes spearmint extract, apple mint extract, peppermint extract, lemon balm extract, sweet basil extract, golden lemon thyme extract, pineapple extract, sage extract, lavender extract, rosemary extract, chamomile extract, marjoram extract, chinensis extract, and hemp leaf sprout. It may further include a natural extract selected from the group consisting of extracts and mixtures thereof.
본 발명의 다른 일 실시예에 따른 기능성 화장료 조성물은 상기 피부 안티폴루션용 조성물을 포함할 수 있다. A functional cosmetic composition according to another embodiment of the present invention may include the skin anti-pollution composition.
본 발명의 다른 일 실시예에 따른 기능성 식품 조성물은 상기 피부 안티폴루션용 조성물을 포함할 수 있다. A functional food composition according to another embodiment of the present invention may include the skin anti-pollution composition.
이하, 본 발명을 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에서 말하는 "세포 보호"는 세포독성이 없고, 환원력 및 DPPH 라디칼 소거능이 높아 항산화 활성이 뛰어나며, 활성산소종 생산, DNA 손상, 세포사멸 및 미토콘드리아 막 손상을 억제하는 효과를 나타내는 것을 포함하는 것으로 한다.“Cell protection” as used in the present invention includes the absence of cytotoxicity, excellent antioxidant activity due to high reducing power and DPPH radical scavenging ability, and the effect of suppressing reactive oxygen species production, DNA damage, apoptosis, and mitochondrial membrane damage. do.
본 명세서에서 "추출물(extract)"이란 생약을 적절한 침출액으로 짜내고 침출액을 증발시켜 농축한 제제를 의미하는 것으로, 이에 제한되지는 않으나, 추출처리에 의해 얻어지는 추출액, 추출액의 희석액 또는 농축액, 추출 액을 건조하여 얻어지는 건조물, 이들의 조정제물 또는 정제물일 수 있다.In this specification, “extract” refers to a preparation obtained by squeezing a herbal medicine into an appropriate leachate and evaporating and concentrating the leachate. It is not limited thereto, but includes, but is not limited to, the extract obtained through extraction processing, the diluted or concentrated liquid of the extract, and the extract liquid. It may be a dried product obtained by drying, a crude product thereof, or a purified product.
본 명세서에서 "유효성분"이란 단독으로 목적하는 활성을 나타내거나 또는 그 자체는 활성이 없는 담체와 함께 활성을 나타낼 수 있는 성분을 의미한다.In this specification, “active ingredient” refers to an ingredient that exhibits the desired activity alone or can exhibit activity in combination with a carrier that is not active on its own.
본 발명에서 말하는 '피부 안티폴루션(Anti-pollution)'은 미세먼지, 유기오염원 또는 무기오염원 등의 오염물 질에 의한 피부 오염, 피부 세포 사멸 또는 피부 세포 증식 저해, 또는 피부상태 저하를 개선하는 것을 말한다.'Skin anti-pollution' as used in the present invention refers to improving skin contamination, skin cell death, inhibition of skin cell proliferation, or deterioration of skin condition caused by contaminants such as fine dust, organic pollutants, or inorganic pollutants. says
본 발명에서 오염물질은 미세먼지, 다환 방향족 탄화수소, 알데하이드류 및 질소산화물류를 포함하는 것일 수 있다.In the present invention, pollutants may include fine dust, polycyclic aromatic hydrocarbons, aldehydes, and nitrogen oxides.
본 발명의 일 실시예에 따른 피부 안티폴루션용 조성물은 바나나 껍질 추출물을 유효 성분으로 포함한다. A composition for skin anti-pollution according to an embodiment of the present invention includes banana peel extract as an active ingredient.
상기 바나나는 당질이 많은 알칼리성 식품으로 칼륨, 카로틴, 비타민 C를 많이 함유하고 있다. 펙틴이 풍부하여 정장작용을 하고, 식이 섬유가 풍부하여 지방 분해와 변비, 숙변 제거에 효과가 있으며, 함유된 칼륨이 나트륨을 몸에서 배출시켜 고혈압 예방에도 도움을 줄 수 있다. 바나나의 잎자루에서는 섬유를 얻고, 잎의 점액에서는 검은색 염료를 채취하기도 한다.The banana is an alkaline food rich in sugar and contains a lot of potassium, carotene, and vitamin C. It is rich in pectin, which helps regulate the intestines. It is rich in dietary fiber, so it is effective in breaking down fat and eliminating constipation and stool. The potassium it contains can help prevent high blood pressure by excreting sodium from the body. Fiber is obtained from the petioles of bananas, and black dye is also collected from the mucus of the leaves.
본 발명은 껍질(과피) 추출물을 활용함으로써, 과육 추출물에 비해 플라보노이드, 폴리페놀 등의 천연 유래 화합물을 유효 성분으로 이용할 수 있다. 뿐만 아니라, 비가식성 부산물로 폐기되고 있는 과일의 껍질을 활용함으로써 생산 단가를 절감할 수 있고 환경친화적이다.The present invention utilizes peel (pericarp) extract, so that naturally derived compounds such as flavonoids and polyphenols can be used as active ingredients compared to pulp extracts. In addition, by using the peel of fruit that is discarded as an inedible by-product, production costs can be reduced and it is environmentally friendly.
즉, 본 발명은 바나나 과육이 아닌, 바나나 껍질을 주요 구성으로 이용하는 것을 특징으로 하는 바, 일반적으로 과일과 같은 식물성 재료를 가공한 후 부산물로 발생되는 껍질들은 대부분 쓰레기로 폐기 처분되고 있는 실정을 고려할 때, 본 발명은 바나나 과육은 별도 제품으로 제조되고, 폐기 예정인 바나나 껍질을 이용하므로, 폐기물 발생 감소라는 측면에서 친환경 특성이 있다.In other words, the present invention is characterized by using banana peel, not banana flesh, as the main component, taking into account the fact that most peels generated as a by-product after processing vegetable materials such as fruits are generally discarded as waste. In this case, the present invention has eco-friendly characteristics in terms of reducing waste generation because banana flesh is manufactured as a separate product and banana peels that are scheduled to be discarded are used.
상기 안티폴루션(anti-pollution)은 환경 유해인자 등 외부 유해 환경의 자극으로부터 발생될 수 있는 염증반응을 억제시킬 수 있음을 의미한다.The anti-pollution means that it can suppress inflammatory reactions that may occur from external harmful environmental stimuli such as environmental harmful factors.
상기 염증 반응(inflammatory response)은 항원을 인지한 대식세포, 호중구 등과 같은 면역세포로부터 다양한 염증매개물질인 NO, PGE2 및 염증성 사이토카인 등을 분비하면서 일어나게 된다.The inflammatory response occurs when immune cells such as macrophages and neutrophils that recognize antigens secrete various inflammatory mediators such as NO, PGE 2 , and inflammatory cytokines.
상기 NO는 염증반응의 지표물질로 사이토카인의 자극, 미생물 침입 등으로 세포가 활성화되어 생성되며, L-아르기닌(L-arginine)에서 NOS(nitric oxide synthase)에 의해 생성된다.The NO is an indicator of inflammatory response and is produced when cells are activated due to stimulation of cytokines, microbial invasion, etc., and is produced by NOS (nitric oxide synthase) from L-arginine.
상기 NOS는 neuronalNOS(nNOS, NOS1), inducibleNOS(iNOS, NOS2), endothelialNOS(eNOS, NOS3) 의 세가지 형태로 존재하며, 이 중에서 염증반응조절 및 NO 생성의 중요한 역할은 iNOS에 의해 일어난다.The NOS exists in three forms: neuronalNOS (nNOS, NOS1), inducibleNOS (iNOS, NOS2), and endothelialNOS (eNOS, NOS3). Among these, iNOS plays an important role in regulating inflammatory responses and producing NO.
PG는 COX(cyclooxygenase) 효소에 의해 생성되며 COX는 COX-1과 COX-2 두 종류로 존재하며, 상기 COX-1은 대부분의 조직에 존재하며 PG 생성에 관여하고, COX-2는 사이토카인(cytokine)등에 발현이 증가되어 많은 PG를 생성시킴으로 염증 반응을 유발한다.PG is produced by COX (cyclooxygenase) enzyme, and COX exists in two types, COX-1 and COX-2. COX-1 is present in most tissues and is involved in PG production, and COX-2 is a cytokine ( The expression of cytokines increases, producing a large amount of PG, thereby causing an inflammatory response.
한편, LPS(lipopolysaccharide)는 외부의 여러 이물질 중 TLR4(toll-like receptor 4)에 의해 인식되는 박테리아 내독소로, 대식세포를 활성화시켜 염증반응을 일으키는 주요 인자 중 하나이다. 활성화된 TLR4는 주요 신호 전달 경로인 NF-ĸB, MAPK 두가지 경로를 활성화시킨다. Meanwhile, LPS (lipopolysaccharide) is a bacterial endotoxin recognized by TLR4 (toll-like receptor 4) among various external foreign substances, and is one of the major factors that cause inflammatory reactions by activating macrophages. Activated TLR4 activates two major signaling pathways, NF-ĸB and MAPK.
상기 MAPK를 구성하는 ERK1/2, JNK, p38은 전사 조절 인자인 ATF, CREB, STAT3, NF-ĸB를 활성화시킨다. 그 중에서도 상기 NF-ĸB는 면역반응, 세포사멸, 염증작용 등에 관여하는 중요한 전사인자로, 세포 내부에서 여러 단계의 신호 전달 과정을 거쳐 활성화 되어 핵 안으로 이동하여 DNA와 결합하고, 이후 transcription 단계를 거쳐 염증성 사이토카인인 TNF(tumor necrosis factor)- α, IL(interleukin)-1β 및 IL(interleukin)-6과 염증성 단백질인 COX(cyclooxygenase)-2, iNOS(inducible nitric oxide synthase)와 같은 염증성 단백질 유전자 발현을 증가시켜 최종적으로 NO(nitric oxide), PGE2(prostaglandin E2) 등을 생성시킴으로써 염증 부위로 염증 반응을 매개하게 된다.ERK1/2, JNK, and p38, which constitute the MAPK, activate transcriptional regulators ATF, CREB, STAT3, and NF-ĸB. Among them, NF-ĸB is an important transcription factor involved in immune responses, cell death, and inflammation. It is activated through several stages of signal transduction inside the cell, moves into the nucleus, binds to DNA, and then goes through the transcription stage. Gene expression of inflammatory proteins such as inflammatory cytokines, TNF (tumor necrosis factor)-α, IL (interleukin)-1β, and IL (interleukin)-6, and inflammatory proteins, such as COX (cyclooxygenase)-2 and iNOS (inducible nitric oxide synthase). increases and ultimately produces NO (nitric oxide), PGE 2 (prostaglandin E 2 ), etc., thereby mediating the inflammatory response to the inflammatory site.
상기 조성물은 NO, PGE2 및 염증성 사이토카인 생성 억제를 통해 항염 활성을 나타내는 것이다.The composition exhibits anti-inflammatory activity through inhibition of NO, PGE 2 and inflammatory cytokine production.
보다 구체적으로, COX-2, iNOS와 같은 염증성 단백질 유전자 발현을 감소시킴으로써 NO 및 PGE2의 생성을 억제시킬 수 있다.More specifically, the production of NO and PGE 2 can be suppressed by reducing the expression of inflammatory protein genes such as COX-2 and iNOS.
또한, 상기 염증성 사이토카인은 IL-1, IL-6, TNF-α 등이 있으며, 본원발명에서는 IL(interleukin)-6 및 IL(interleukin)-1β, 생성 억제 활성을 통해 항염 활성을 나타낼 수 있다.In addition, the inflammatory cytokines include IL-1, IL-6, and TNF-α, and in the present invention, they can exhibit anti-inflammatory activity through inhibiting the production of IL (interleukin)-6 and IL (interleukin)-1β. .
상기 NO, PGE2 및 염증성 사이토카인은 환경 유해인자로 유도된 것이다.The NO, PGE 2 and inflammatory cytokines are induced by environmental harmful factors.
상기 환경 유해인자는 미세먼지, 차량 배기가스, 다이옥신, 벤조피렌 및 중금속으로 이루어진 군에서 선택되는 것이다.The environmental harmful factors are selected from the group consisting of fine dust, vehicle exhaust gas, dioxin, benzopyrene, and heavy metals.
본원발명에서 상기 환경 유해인자는 미세먼지일 수 있다.In the present invention, the environmental harmful factor may be fine dust.
상기 미세먼지는 먼지의 일종으로, 대기중에 떠다니거나 흩날려 내려오는 입자상 물질을 말하며, 석탄석유 등의 화석연료를 태울 때나 공장자동차 등의 배출가스에서 많이 발생한다. 상기 미세먼지를 이루는 성분은 미세먼지가 발생한 지역이나 계절, 기상조건 등에 달라질 수 있으며, 일반적으로는 대기오염물질이 공기 중에서 반응하여 형성된 황산염, 질산염 등과 석탄, 석유 등 화석연료를 태우는 과정에서 발생하는 검댕, 지표면 흙먼지 등에서 생기는 광물 등으로 구성된다.The fine dust is a type of dust and refers to particulate matter that floats or blows down in the atmosphere, and is often generated when burning fossil fuels such as coal and oil or from exhaust gases such as factory vehicles. The components that make up the fine dust may vary depending on the region, season, weather conditions, etc. where the fine dust occurs, and generally, sulfates and nitrates formed when air pollutants react in the air, and those generated in the process of burning fossil fuels such as coal and oil. It is composed of soot and minerals generated from surface dirt.
먼지는 입자 크기에 따라 50μm 이하인 총먼지(TSP, Total Suspended Particles)와 입자크기가 매우 작은 미세먼지(PM, Particulate Matter)로 구분한다. 상기 미세먼지는 다시 지름이 10μm보다 작은 미세먼지(PM10)와 지름이 2.5μm보다 작은 미세먼지(PM2.5)로 나뉜다. PM10이 사람의 머리카락 지름(50~70μm)보다 약 1/5~1/7 정도로 작은 크기라면, PM2.5는 머리카락의 약 1/20~1/30에 불과할 정도로 매우 작다. 이에, 눈에 보이지 않을 만큼 매우 작은 미세먼지는 대기 중에 머물러 있다 호흡기를 거쳐 폐 등에 침투하거나 혈관을 따라 체내로 이동해 들어와 건강에 악영향을 끼칠 수 있다.Depending on the particle size, dust is divided into Total Suspended Particles (TSP), which are 50μm or less, and Particulate Matter, which is very small. The fine dust is further divided into fine dust with a diameter smaller than 10 μm (PM10) and fine dust with a diameter smaller than 2.5 μm (PM2.5). If PM10 is about 1/5 to 1/7 smaller than the diameter of a human hair (50 to 70 μm), PM2.5 is very small, only about 1/20 to 1/30 of a human hair. Accordingly, fine dust, which is so small that it is invisible to the eye, stays in the air and can infiltrate the lungs through the respiratory tract or move into the body along the blood vessels, causing adverse effects on health.
상기 미세먼지에 급성 노출 시, 기도 자극으로 인한 기침 및 호흡 곤란, 천식 악화, 부정맥 등이 발생하며, 미세먼지 만성 노출 시, 폐기능 감소, 만성 기관지염이 증가하며, 사망률이 증가될 수 있으며 피부 노화, 알레르기 질환의 악화 등 다양한 질환의 원인이 될 수 있다. When acutely exposed to fine dust, coughing, difficulty breathing, worsening asthma, and arrhythmia occur due to airway irritation, and when chronically exposed to fine dust, lung function decreases, chronic bronchitis increases, mortality rate increases, and skin aging occurs. , can cause various diseases such as exacerbation of allergic diseases.
뿐만 아니라, 미세먼지는 세포 내 염증반응과 산화 스트레스를 유발할 수 있다. In addition, fine dust can cause intracellular inflammatory responses and oxidative stress.
상기 산화 스트레스는 활성산소종(ROS)의 생성과 이를 제거하는 항산화 반응 간의 불균형으로 인해 세포 내의 활성산소종(ROS)이 증가하여 DNA나 단백질, 지질(lipid) 등을 산화시켜 이의 구조와 기능에 변화를 초래하고 결국 세포의 기능 또는 구조적 손상을 유발시키는 현상을 의미한다. The oxidative stress is caused by an imbalance between the production of reactive oxygen species (ROS) and the antioxidant reaction that removes them, resulting in an increase in reactive oxygen species (ROS) within cells, which oxidizes DNA, proteins, lipids, etc., damaging their structure and function. It refers to a phenomenon that causes changes and ultimately causes functional or structural damage to cells.
상기 바나나 껍질 추출물은 물, C1 내지 C6의 저급 알코올 및 이들의 혼합물로 이루어진 군으로부터 선택된 추출 용매를 이용하여 추출되는 것이다.The banana peel extract is extracted using an extraction solvent selected from the group consisting of water, C 1 to C 6 lower alcohols, and mixtures thereof.
구체적으로, 바나나 껍질 추출물을 제조하기 위해서는 바나나 껍질을 세척하는 단계; 세척 후 건조시키는 단계; 건조 후 바나나 껍질을 분쇄하는 단계; 유기 용매를 사용하여 상기 분쇄물을 침출시키는 단계; 시료를 침출 후 건조시키는 단계; 물을 이용하여 침출시키는 단계; 및 침출하는 단계를 포함하여, 바나나 껍질 추출물을 획득할 수 있다.Specifically, to prepare banana peel extract, the steps include washing the banana peel; Drying after washing; Grinding banana peels after drying; leaching the pulverized material using an organic solvent; Leaching and drying the sample; Leaching using water; And including the step of leaching, a banana peel extract can be obtained.
상기 유기 용매를 사용하여 추출한 추출물은 유기 용매를 사용하여 분획을 실시하는 단계를 더 포함할 수 있으며, 상기 추출물을 제조하는 방법은 초음파 추출법, 침출법 및 환류 추출법 등 당업계의 통상적인 추출 방법일 수 있다. The extract extracted using the organic solvent may further include the step of performing fractionation using the organic solvent, and the method of preparing the extract may be a conventional extraction method in the art, such as ultrasonic extraction, leaching, and reflux extraction. You can.
구체적으로 세척 및 건조로 이물질이 제거된 바나나 껍질 추출물을 물, 탄소수 1 내지 6의 알코올 또는 이들의 혼합 용매로 추출한 추출물일 수 있으며, 상기 용매들을 순차적으로 시료에 적용하여 추출한 추출물일 수 있다.Specifically, it may be an extract obtained by extracting a banana peel extract from which foreign substances have been removed by washing and drying with water, alcohol with 1 to 6 carbon atoms, or a mixed solvent thereof, and may be an extract obtained by sequentially applying the solvents to the sample.
상기 환류 추출법은 물, 탄소수 1 내지 6의 알코올 100 mL기준으로, 천연물의 분쇄물 10 내지 30g, 환류 시간 1 내지 3시간 및 50 내지 100%의 탄소수 1 내지 6의 알코올 또는 물에 의한다. 보다 구체적으로, 탄소수 1 내지 6의 알코올 100 mL 또는 물 100 mL 기준으로, 천연물의 분쇄물 10 내지 20g, 환류 시간 1 내지 2시간 및 70 내지 90%의 탄소수 1 내지 4의 알코올 또는 물에 의한 것이다.The reflux extraction method is based on 100 mL of water and alcohol with 1 to 6 carbon atoms, 10 to 30 g of pulverized natural product, reflux time of 1 to 3 hours, and 50 to 100% of alcohol or water with 1 to 6 carbon atoms. More specifically, based on 100 mL of alcohol with 1 to 6 carbon atoms or 100 mL of water, 10 to 20 g of pulverized natural product, reflux time of 1 to 2 hours, and 70 to 90% of alcohol or water with 1 to 4 carbon atoms. .
상기 침출법은 15 내지 30℃, 24 내지 72시간 동안 진행하며, 추출 용매로 물 또는 50 내지 100%의 탄소수 1 내지 6의 알코올을 이용한다. 보다 구체적으로는 20 내지 25℃, 30 내지 54시간 동안 진행하며, 추출 용매는 물 또는 70 내지 80%의 탄소수 1 내지 6의 알코올에 의한 것이다.The leaching method is carried out at 15 to 30°C for 24 to 72 hours, and water or 50 to 100% alcohol with 1 to 6 carbon atoms is used as the extraction solvent. More specifically, the extraction is performed at 20 to 25°C for 30 to 54 hours, and the extraction solvent is water or 70 to 80% alcohol with 1 to 6 carbon atoms.
상기 초음파 추출법은 30 내지 50℃, 0.5 내지 2.5시간 동안 반응을 진행하며, 추출용매는 물 또는 50 내지 100%의 탄소수 1 내지 6의 알코올에 의한 것이다. 구체적으로는 40 내지 50℃, 1 내지 2.5시간 동안 추출하며, 추출용매로 물 또는 70 내지 80%의 탄소수 1 내지 6의 알코올에 의한 것이다.The ultrasonic extraction method proceeds at 30 to 50°C for 0.5 to 2.5 hours, and the extraction solvent is water or 50 to 100% alcohol with 1 to 6 carbon atoms. Specifically, extraction is performed at 40 to 50°C for 1 to 2.5 hours, and the extraction solvent is water or 70 to 80% alcohol with 1 to 6 carbon atoms.
상기 추출 용매는 시료의 중량 기준으로 2 내지 50배를 사용할 수 있으며, 보다 구체적으로는 2 내지 20배이다. 추출을 위해 시료는 추출 용매에서 추출을 위해 1 내지 72시간 동안 방치될 수 있으며, 보다 구체적으로 24 내지 48시간 동안 방치될 수 있다.The extraction solvent can be used in an amount of 2 to 50 times, more specifically, 2 to 20 times the weight of the sample. For extraction, the sample may be left in the extraction solvent for 1 to 72 hours, more specifically, 24 to 48 hours.
추출 후, 추출물은 새로운 분획 용매를 순차적으로 적용하여 분획할 수 있다. 분획 시 사용하는 분획 용매는 상기 용매는 물, 헥산, 부탄올, 에틸아세트산, 에틸 아세테이트, 메틸렌클로라이드 및 이들의 혼합물로 이루어진 군으로부터 선택된 어느 하나 이상이며, 바람직하게는 에틸아세테이트 또는 메틸렌클로라이드이다. 추출물 또는 분획물을 얻은 후에는 농축 또는 동결건조 등의 방법을 추가적으로 사용할 수 있다.After extraction, the extract can be fractionated by sequentially applying a new fractionation solvent. The fractionating solvent used during fractionation is at least one selected from the group consisting of water, hexane, butanol, ethyl acetic acid, ethyl acetate, methylene chloride, and mixtures thereof, and is preferably ethyl acetate or methylene chloride. After obtaining the extract or fraction, additional methods such as concentration or freeze-drying can be used.
상기 피부 안티폴루션용 조성물은 스피아민트 추출물, 애플민트 추출물, 페퍼민트 추출물, 레몬밤 추출물, 스위트 바질 추출물, 골든레몬타임 추출물, 파인애플 추출물, 세이지 추출물, 라벤더 추출물, 로즈마리 추출물, 카모마일 추출물, 마조람 추출물, 넘나물 추출물, 꿀풀 추출물 및 이들의 혼합으로 이루어진 군으로부터 선택된 천연 추출물을 추가로 포함할 수 있고, 바람직하게는 마조람 추출물, 넘나물 추출물 및 꿀풀 추출물을 추가로 포함할 수 있다. The composition for skin anti-pollution includes spearmint extract, apple mint extract, peppermint extract, lemon balm extract, sweet basil extract, golden lemon thyme extract, pineapple extract, sage extract, lavender extract, rosemary extract, chamomile extract, marjoram extract, It may further include a natural extract selected from the group consisting of L. chinensis extract, L. chinensis extract, and mixtures thereof, and preferably may further include marjoram extract, L. L. plant extract, and L. plant extract.
상기 마조람(Origanum majorana)은 굴풀과의 여러해살이풀이로, 잎은 넓은 달걀 모양이고 6~8월에 담황색 또는 흰색 꽃이 핀다. 신경진정, 진통, 제음, 방부성, 항경련, 원기촉진, 혈관확장, 상처치료, 항바이러스, 살균, 구풍(驅風), 발한 등의 효과가 있는 허브로서, 향기가 매우 강하여 향료로 쓰며, 약재로도 사용한다.The marjoram (Origanum majorana) is a perennial plant of the Oysteraceae family. Its leaves are broadly egg-shaped and light yellow or white flowers bloom from June to August. It is a herb with soothing, analgesic, antiseptic, antiseptic, antispasmodic, stimulating, vasodilating, wound healing, antiviral, sterilizing, carminative, and diaphoretic effects. It has a very strong scent and is used as a flavoring and medicinal agent. It is also used as
상기 넘나물(Hemerocallis fulva L.)은 원추리과 원추리속의 여러해살이풀로, 원추리라고도 한다. 주로 산지에서 자라며, 높이 약 1m이다. 뿌리는 사방으로 퍼지고 원뿔 모양으로 굵어지는 것이 있고, 잎은 2줄로 늘어서고 길이 약 80cm, 나비 1.2∼2.5cm이며 끝이 처진다. 꽃은 7∼8월에 핀다. 꽃줄기는 잎 사이에서 나와서 자라고, 끝에서 가지가 갈라져서 6∼8개의 꽃이 총상꽃차례로 달린다. 빛깔은 주황색이고 길이 10∼13cm, 통부분은 길이 1∼2cm이다. 포는 줄 모양 바소꼴이며 길이 2∼8cm이고, 작은꽃줄기는 길이 1∼2cm이다. 흔히 관상용으로 심으나, 어린순은 나물로 먹고, 꽃을 중국요리에 사용하기도 한다.Hemerocallis fulva L. is a perennial plant of the genus Daylily of the family Daylily and is also called daylily. It mainly grows in mountainous areas and is about 1m tall. The roots spread in all directions and thicken into a cone shape, and the leaves are arranged in two rows, about 80cm long and 1.2-2.5cm wide, with drooping ends. Flowers bloom from July to August. The flower stem grows out from between the leaves, and branches split at the end to produce 6 to 8 flowers in a raceme. The color is orange, the length is 10 to 13 cm, and the tube is 1 to 2 cm long. The bracts are line-shaped and lanceolate, 2 to 8 cm long, and the floret stems are 1 to 2 cm long. It is commonly planted for ornamental purposes, but the young shoots are eaten as vegetables and the flowers are used in Chinese cuisine.
상기 꿀풀(Prunella asiatica Nakai)은 전국의 산과 들에 흔하게 자라는 여러해살이풀로 중국과 일본에도 분포한다. 뿌리줄기가 있다. 줄기는 붉은색이 돌며, 털이 많고, 높이 20-60cm다. 잎은 마주나며, 난형 또는 난상 타원형, 가장자리가 밋밋하거나 톱니가 조금 있다. 꽃은 5-7월에 줄기 끝의 수상꽃 차례에 빽빽이 달리며, 보라색, 분홍색, 흰색, 입술 모양이다. 꽃받침은 입술 모양, 5갈래로 갈라진다. 화관은 아랫입술이 3갈래로 갈라진다. 수술은 4개, 2개가 길다. 열매는 소견과이며, 4개로 갈라지고, 노란빛이 도는 갈색으로 익는다.The above-mentioned Prunella asiatica Nakai is a perennial herb that commonly grows in mountains and fields across the country and is also distributed in China and Japan. There is a rhizome. The stem is red, hairy, and 20-60cm high. The leaves are opposite each other, ovate or oval-shaped, and have smooth or slightly serrated edges. Flowers grow densely in spikes at the ends of stems from May to July, and are purple, pink, white, and lip-shaped. The calyx is shaped like a lip and is divided into five branches. The lower lip of the corolla is split into three parts. There are 4 stamens, 2 of which are long. The fruit is a small nut, splits into four pieces, and ripens to yellowish brown.
상기 조성물은 바나나 껍질 추출물을 유효 성분으로 포함하며, 마조람 추출물, 넘나물 추출물 및 꿀풀 추출물을 추가로 포함할 수 있다. 구체적으로 상기 바나나 껍질 추출물 100 중량부에 대하여, 마조람 추출물 10 내지 20 중량부, 넘나물 추출물 10 내지 20 중량부 및 꿀풀 추출물 10 내지 20 중량부로 포함할 수 있다. 상기 범위 내에서 혼합하여 사용 시, 복합 추출물 간의 상호 작용으로 인해 피부 안티폴루션 효과가 상승하게 되며, 식품 조성물로 제공 시, 기호도가 높은 식품으로 제공이 가능하고, 화장료 조성물로 제공 시, 기호도 높은 향을 제공하고, 발림성이 우수한 제품으로 제조가 가능하게 된다. The composition contains banana peel extract as an active ingredient, and may further include marjoram extract, Chrysanthemum extract, and Lamifolia extract. Specifically, based on 100 parts by weight of the banana peel extract, it may include 10 to 20 parts by weight of marjoram extract, 10 to 20 parts by weight of Chrysanthemum extract, and 10 to 20 parts by weight of Lamifolia extract. When mixed and used within the above range, the skin anti-pollution effect increases due to the interaction between the complex extracts. When provided as a food composition, it can be provided as a food with high preference, and when provided as a cosmetic composition, it has a high preference. It provides fragrance and can be manufactured as a product with excellent spreadability.
본 발명의 다른 일 실시예에 따른 화장료 조성물은 상기 바나나 껍?? 추출물을 유효성분으로 포함하는 안티폴루션용 조성물을 포함하는 것이다.The cosmetic composition according to another embodiment of the present invention is the banana peel?? It includes an anti-pollution composition containing an extract as an active ingredient.
본원발명의 화장료 조성물은 해당 분야에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 및 스프레이 등으로 제형화 될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형, 수중유(O/W)형 또는 유중수(W/O)형의 제형 또는 연고로 제조될 수 있다.The cosmetic composition of the present invention can be prepared in any formulation commonly prepared in the field, for example, solution, suspension, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, It can be formulated as powder foundation, emulsion foundation, wax foundation, and spray, but is not limited thereto. More specifically, flexible lotion, nourishing lotion, nourishing cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder formulation, oil-in-water (O/W) type or water-in-oil type. It can be prepared as a (W/O) type formulation or ointment.
또한, 상기 화장료 조성물 이외에도 피부학적으로 허용된 매질 또는 기제를 함유함으로써 당업계에서 통상적으로 사용되는 국소 적용 또는 전신 적용할 수 있는 보조제 형태로 제조될 수 있다.In addition, in addition to the above cosmetic composition, it can be prepared in the form of an adjuvant for topical or systemic application commonly used in the art by containing a dermatologically acceptable medium or base.
상기 화장료 조성물로 제조될 수 있는 적합한 화장품 제형으로는 예를 들면, 수렴화장수, 유연화장수, 영양화장수, 각종 크림, 에센스, 팩, 파운데이션 등과 같은 화장품류와 클렌징, 세안제, 비누, 트리트먼트 또는 미용액 등이 있다. Suitable cosmetic formulations that can be manufactured from the above cosmetic composition include, for example, cosmetics such as astringent lotion, softening lotion, nourishing lotion, various creams, essences, packs, foundations, etc., as well as cleansers, face washes, soaps, treatments, or beauty essences. There is.
구체적인 제형으로서는 스킨로션, 스킨 소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 맛사지크림, 영양크림, 모이스처 크림, 핸드크림, 에센스, 영양에센스, 팩, 비누, 샴푸, 클렌징 폼, 클렌징로션, 클렌징크림, 바디로션, 바디클렌저, 유액, 프레스파우더, 루스파우더 또는 아이섀도우 등의 제형을 포함한다.Specific formulations include skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutritional lotion, massage cream, nutritional cream, moisture cream, hand cream, essence, nutritional essence, pack, soap, shampoo, and cleansing foam. , including formulations such as cleansing lotion, cleansing cream, body lotion, body cleanser, emulsion, pressed powder, loose powder, or eye shadow.
본 발명의 또 다른 일 실시예에 따른 식품 조성물은 상기 바나나 껍질 추출물을 유효성분으로 포함하는 안티폴루션용 조성물을 유효성분으로 포함하는 것이다.A food composition according to another embodiment of the present invention contains an anti-pollution composition containing the banana peel extract as an active ingredient.
본 발명에 따른 식품 조성물은 분말, 과립, 정제, 캡슐, 시럽 또는 음료의 형태로 제공될 수 있으며, 이외에 다른 식품 또는 식품 첨가물과 함께 사용되고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분의 혼합 양은 그의 사용 목적 예를 들어 예방, 건강 또는 치료적 처치에 따라 적합하게 결정될 수 있다.The food composition according to the present invention may be provided in the form of powder, granules, tablets, capsules, syrup or beverage, and may be used with other foods or food additives, and may be used appropriately according to conventional methods. The mixing amount of the active ingredient can be appropriately determined depending on its purpose of use, such as prevention, health, or therapeutic treatment.
구체적인 예로, 상기 식품 조성물을 이용하여 미세먼지에 대한 안티폴루션 활성을 증강시킬 수 있는 가공식품을 제조할 수 있다. 이런 가공식품에는 예를 들어, 과자, 음료, 주류, 발효식품, 통조림, 우유가공식품, 육류가공식품, 국수 등을 포함한다. 과자는 비스킷, 파이, 케익, 빵, 캔디, 젤리, 껌, 시리얼 등을 포함한다. 음료는 음용수, 탄산음료, 기능성 이온음료, 기능성 이온음료, 주스(예를 들어, 사과, 배, 포도, 알로에, 감귤, 복숭아, 당근, 토마토 주스 등), 식혜 등을 포함한다. 주류는 청주, 위스키, 소주, 맥주, 양주, 과실주 등을 포함한다. 발효식품은 간장, 된장, 고추장 등을 포함한다. 통조림은 수산물 통조림(예들 들어, 참치, 고등어, 꽁치, 소라 통조림 등), 축산물 통조림(쇠고기, 돼지고기, 닭고기, 칠면조 통조림 등), 농산물 통조림(옥수수, 복숭아, 파일애플 통조림 등)을 포함한다. 우유가공식품은 치즈, 버터, 요구르트 등을 포함한다. 육류가공식품은 돈까스, 비프까스, 치킨까스, 소세지. 탕수육, 너겟류, 너비아니 등을 포함한다. 밀봉포장생면 등의 국수를 포함한다. 이 외에도 상기 조성물은 레토르트식품, 스프류 등에 사용될 수 있다.As a specific example, the above food composition can be used to produce processed food that can enhance anti-pollution activity against fine dust. These processed foods include, for example, snacks, beverages, alcoholic beverages, fermented foods, canned foods, processed milk foods, processed meat foods, noodles, etc. Confectionery includes biscuits, pies, cakes, bread, candy, jellies, gum, cereals, etc. Beverages include drinking water, carbonated beverages, functional ionic beverages, functional ionic beverages, juices (e.g., apple, pear, grape, aloe, tangerine, peach, carrot, tomato juice, etc.), Sikhye, etc. Alcoholic beverages include sake, whiskey, soju, beer, liquor, and fruit wine. Fermented foods include soy sauce, soybean paste, and red pepper paste. Canned food includes canned seafood (e.g., canned tuna, mackerel, saury, canned conch, etc.), canned livestock products (canned beef, pork, chicken, turkey, etc.), and canned agricultural products (canned corn, peaches, canned file apple, etc.). Milk processed foods include cheese, butter, yogurt, etc. Processed meat products include pork cutlet, beef cutlet, chicken cutlet, and sausage. Includes sweet and sour pork, nuggets, neobiani, etc. Includes noodles such as raw noodles in sealed packages. In addition, the composition can be used in retort foods, soups, etc.
본 발명은 미세먼지, 유기성 또는 무기성 오염원 등에 대한 피부 항오염 효과를 가져, 오염원에 의한 피부 트러블 등의 문제를 방지하고, 피부 자극을 최소화할 수 있고, 항산화 효과가 우수하다.The present invention has an anti-pollution effect on the skin against fine dust, organic or inorganic pollutants, etc., prevents problems such as skin problems caused by pollutants, minimizes skin irritation, and has an excellent antioxidant effect.
또한, 피부 도포성 및 흡수성이 우수하고, 선호도가 높은 화장료 제형으로 이용 가능하고, 기호도 높은 기능성 식품 조성물로 제공될 수 있다.In addition, it has excellent skin applicability and absorption, can be used as a cosmetic formulation with high preference, and can be provided as a functional food composition with high preference.
도 1은 본 발명의 일 실시예에 따른 세포 독성 평가 결과이다.
도 2는 본 발명의 일 실시예에 따른 세포 독성 평가 결과이다.
도 3은 본 발명의 일 실시예에 따른 조성물에 의한 NO 생성 억제 실험 결과이다.
도 4은 본 발명의 일 실시예에 따른 조성물에 의한 PGE2 생성 억제 실험 결과이다.
도 5는 본 발명의 일 실시예에 따른 조성물에 의한 사이토카인 생성 억제 실험 결과이다.
도 6은 본 발명의 일 실시예에 따른 조성물에 의한 사이토카인 생성 억제 실험 결과이다.Figure 1 shows the results of cytotoxicity evaluation according to an embodiment of the present invention.
Figure 2 shows the results of cytotoxicity evaluation according to an embodiment of the present invention.
Figure 3 shows the results of a NO production inhibition test by a composition according to an embodiment of the present invention.
Figure 4 shows the results of an experiment on inhibition of PGE 2 production by a composition according to an embodiment of the present invention.
Figure 5 shows the results of an experiment on inhibition of cytokine production by a composition according to an embodiment of the present invention.
Figure 6 shows the results of an experiment on inhibition of cytokine production by a composition according to an embodiment of the present invention.
이하, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예에 대하여 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다.Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily implement it. However, the present invention may be implemented in many different forms and is not limited to the embodiments described herein.
제조예 1Manufacturing Example 1
바나나 껍질 추출물의 제조Preparation of banana peel extract
바나나 껍질을 세척 및 건조하고, 분쇄한 뒤 추출 용매인 증류수를 1:10(w:v)의 비율로 가한 다음 완전히 침지 시킨 후, 80℃에서 환류시키면서 3시간씩 3회 반복 추출하였다. 추출액은 Whatman No. 2 여과지로 여과하였다. 여과액은 60℃에서 감압 농축하여 분말 시료를 제조하여 실험에 사용하였다. 열수 추출하고, 농축 여과하여 바나나 껍질 추출물(BF)을 제조하였다.The banana peel was washed, dried, and pulverized. Distilled water as an extraction solvent was added at a ratio of 1:10 (w:v), then completely immersed, and extraction was repeated three times for 3 hours while refluxing at 80°C. The extract was Whatman No. 2 Filtered with filter paper. The filtrate was concentrated under reduced pressure at 60°C to prepare a powder sample and used in the experiment. Banana peel extract (BF) was prepared by hot water extraction and concentration filtration.
제조예 2Production example 2
기타 천연 추출물의 제조Preparation of other natural extracts
마조람, 넘나물 및 꿀풀은 각각 세척 및 건조한 후, 상기 바나나 껍질 추출물과 동일한 방법으로 추출물로 제조하였다. After washing and drying marjoram, dandelion root, and honeysuckle, respectively, the extract was prepared in the same manner as the banana peel extract.
하기 표 1과 같은 중량부 범위 내에서 안티폴루션용 조성물을 제조하였다.An anti-pollution composition was prepared within the weight range as shown in Table 1 below.
(단위 중량부, MF는 마조람 추출물, HF는 넘나물 추출물, PF는 꿀풀 추출물)(Unit weight parts, MF is marjoram extract, HF is ginseng extract, PF is Lamifolia extract)
실험예 1Experimental Example 1
세포 독성 평가Cytotoxicity evaluation
RAW 264.7 세포는 한국 세포 은행(Korea Cell Line Bank, 한국)에서 구입하여 10%(v/v) 태아 소 혈청(FBS), 100 U/ml 페니실린, 100 U/ml 스트렙토마이신이 포함된 둘베코모디파이드 이글 미디엄(in Dulbecco's modified Eagle's medium)을 이용하여 37℃ 및 5% CO2(v/v)의 조건에서 배양하였다.RAW 264.7 cells were purchased from Korea Cell Line Bank (Korea) and incubated with Dulbeccommodia containing 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin, and 100 U/ml streptomycin. The cells were cultured at 37°C and 5% CO 2 (v/v) using Pied Eagle medium (in Dulbecco's modified Eagle's medium).
상기 RAW 264.7 세포에 대한 바나나 껍질 추출물(BF)의 세포 독성을 MTT 환원 분석을 통해 측정하였다.The cytotoxicity of banana peel extract (BF) to the RAW 264.7 cells was measured through MTT reduction assay.
세포를 다양한 농도의 바나나 껍질 추출물(BF)로 처리하였다. 이후, 배지를 제거하고 MTT용액(Sigma-Aldrich Chemical Co.) 0.5mg/ml을 각 well에 분배하고 37℃에서 반응하였다. 3시간 동안 배양한 후, 상등액을 제거하고 DMS를 첨가하여 청색 포르마잔 결정을 10분 동안 용해시켰다. well 당 흡광도는 효소 결합 면역 흡착분석(ELISA) 플레이트 판독기((Dynatech Laboratories, Chantilly, VA, USA)를 사용하여 540nm의 파장에서 흡광도를 측정하였다.Cells were treated with various concentrations of banana peel extract (BF). Afterwards, the medium was removed, and 0.5 mg/ml of MTT solution (Sigma-Aldrich Chemical Co.) was distributed to each well and reacted at 37°C. After incubation for 3 hours, the supernatant was removed and DMS was added to dissolve the blue formazan crystals for 10 minutes. The absorbance per well was measured at a wavelength of 540 nm using an enzyme-linked immunosorbent assay (ELISA) plate reader (Dynatech Laboratories, Chantilly, VA, USA).
도 1을 참조하면, 바나나 껍질 추출물(BF)의 500μg/ml 이하 농도에서 RAW 264.7 세포에 세포독성이 없음을 확인하였고, 도 2는 50 μg/ml의 표준 디젤 미립자 물질(SRM 1650b, 이하 PM2.5이라 함)로 처리된 RAW 264.7 세포에 500μg/ml 미만의 바나나 껍질 추출물(BF)을 RAW 264.7 세포에 투여해도 세포 생존에 유의미한 악영향을 미치지 않음을 확인하였다.Referring to Figure 1, it was confirmed that there was no cytotoxicity to RAW 264.7 cells at a concentration of 500 μg/ml or less of banana peel extract (BF), and Figure 2 shows standard diesel particulate matter (SRM 1650b, hereinafter PM2. It was confirmed that administering less than 500 μg/ml of banana peel extract (BF) to RAW 264.7 cells treated with (referred to as 5) did not have a significant adverse effect on cell survival.
이하 바나나 껍질 추출물(BF)의 농도는 500μg/ml에 대해 피부 안티폴루션 효과에 대해 확인하였으며, 복합 추출물로 제조 시에도 500μg/ml를 기준으로 하였다.Below, the concentration of banana peel extract (BF) was confirmed to have a skin anti-pollution effect at 500 μg/ml, and 500 μg/ml was also used as the standard when manufacturing the complex extract.
NO, PGENO, PGE 22 및 사이토카인의 측정 and measurement of cytokines.
RAW 264.7 세포는 1시간 동안 200 μg/ml 및 500 μg/ml 바나나 껍질 추출물로 처리한 후, 24시간 동안 50 μg/ml PM2.5로 자극하였다. 배지내의 NO 수준은 Griess 시약(Sigma-Aldrich Chemical Co.)을 사용하여 측정된 아질산염의 양에 의해 평가되었다. 세포 조절 배지의 100μL은 10분 동안 동일한 양의 Griess 시약으로 혼합하였다. 흡광도는 ELISA 판독기를 사용하여 540 nm로 측정하고, 아질산 나트륨(NaNO2) 표준 곡선과 비교하여 계산하였다. RAW 264.7 cells were treated with 200 μg/ml and 500 μg/ml banana peel extract for 1 hour and then stimulated with 50 μg/ml PM2.5 for 24 hours. NO levels in the medium were assessed by the amount of nitrite measured using Griess reagent (Sigma-Aldrich Chemical Co.). 100 μL of cell conditioned medium was mixed with an equal amount of Griess reagent for 10 minutes. Absorbance was measured at 540 nm using an ELISA reader and calculated by comparison with a sodium nitrite (NaNO 2 ) standard curve.
또한, PGE2 및 사이토카인 수준을 조사하기 위해, ELISA 키트(R & D Systems Inc., Minneapolis, MN, USA)를 사용하여 배양 상등액을 수집 및 평가하였습니다. 흡광도는 ELISA 판독기를 사용하여 450nm의 파장에서 측정하였다.Additionally, to examine PGE 2 and cytokine levels, culture supernatants were collected and evaluated using an ELISA kit (R & D Systems Inc., Minneapolis, MN, USA). Absorbance was measured at a wavelength of 450 nm using an ELISA reader.
상기 실험에 의한 결과는 도 3 및 도 4와 같이, PM2.5가 처리되지 않은 대조군에 비해 PM2.5 처리는 NO 및 PGE2의 방출을 크게 증가시켰으나, 이 증가는 바나나 껍질 추출물의 처리 농도가 증가함에 따라 크게 감소하였다. The results of the above experiment show that, as shown in Figures 3 and 4, PM2.5 treatment significantly increased the release of NO and PGE 2 compared to the control group that was not treated with PM2.5, but this increase was due to the treatment concentration of banana peel extract. As it increased, it decreased significantly.
이후, 바나나 껍질 추출물이 PM2.5에 의해 iNOS 및 COX-2의 발현을 억제할 수 있는지 여부를 조사하였다. 하기 도 3 및 도 4를 참조하면, RT-PCR 및 웨스턴 블롯 결과에 따라 PM2.5에 의해 증가된 iNOS 및 COX-2의 mRNA 및 단백질 발현은 바나나 껍질 추출물(BF)의 존재 하에서 현저히 억제됨을 확인하였다.Afterwards, we investigated whether banana peel extract could inhibit the expression of iNOS and COX-2 by PM2.5. Referring to Figures 3 and 4 below, it was confirmed that the mRNA and protein expressions of iNOS and COX-2 increased by PM2.5 were significantly suppressed in the presence of banana peel extract (BF) according to RT-PCR and Western blot results. did.
또한, PM2.5 처리에 의해 증가된 전염증성 사이토카인의 생성 및 발현에 대한 바나나 껍질 추출물의 효과는 도 5 및 6과 같다. 구체적으로 PM2.5에 의한 자극 후, 배양 상층액으로 방출되는 IL-6 및 IL-1β를 포함하는 전염증성 사이토카인의 양이 현저하게 증가함을 확인하였다. 그러나, PM2.5에 의한 전염증성 사이토카인의 생성은 바나나 껍질 추출물의 전처리에 의해 현저히 억제함을 확인하였다. Additionally, the effect of banana peel extract on the production and expression of pro-inflammatory cytokines increased by PM2.5 treatment is shown in Figures 5 and 6. Specifically, it was confirmed that after stimulation by PM2.5, the amount of pro-inflammatory cytokines including IL-6 and IL-1β released into the culture supernatant significantly increased. However, it was confirmed that the production of pro-inflammatory cytokines by PM2.5 was significantly inhibited by pretreatment with banana peel extract.
실험예 2Experimental Example 2
복합 추출물에 대한 피부 안티폴루션 효과Skin anti-pollution effect of complex extract
상기 바나나 껍질 추출물에 대한 피부 안티폴루션 효과 확인 결과에 따라, 복합 추출물에 대한 피부 안티폴루션 효과를 동일한 방식으로 실험을 진행하였다. According to the results of confirming the skin anti-pollution effect of the banana peel extract, the skin anti-pollution effect of the complex extract was tested in the same manner.
세포 독성 결과에서도, 동일한 농도(500μg/ml)로 MF, HF 및 PF를 처리하여도 농도에서 RAW 264.7 세포에 세포독성이 없음을 확인하였으며, 혼합된 복합물로 처리 시에도 동일하게 세포 독성이 없음을 확인하였다. In the cytotoxicity results, it was confirmed that there was no cytotoxicity to RAW 264.7 cells even when MF, HF, and PF were treated at the same concentration (500 μg/ml), and there was also no cytotoxicity when treated with the mixed complex. Confirmed.
이후, NO, PGE2 및 사이토카인의 측정에 대해서도 실험을 진행하였다. 상기 실험은 실시예1에 대한 실험 결과로, 상대적인 비교를 위해, 실시예 1을 지수 5로 설정하고, 실시예 2 내지 6에 대해 지수로 평가하였다. Afterwards, experiments were also conducted to measure NO, PGE 2 , and cytokines. The above experiment is the result of the experiment for Example 1. For relative comparison, Example 1 was set to an index of 5, and Examples 2 to 6 were evaluated by the index.
결과는 하기 표 2와 같다. The results are shown in Table 2 below.
(단위 지수)(unit exponent)
상기 실험 결과에 의하면, 실시예 1과 비교하여 실시예 3 내지 5에서 동등 이상의 우수한 NO 및 PGE2 발현 억제 효과를 나타내며, 염증성 사이토카인 생성 억제 효과도 우수함을 확인하였다. According to the above experimental results, it was confirmed that compared to Example 1, Examples 3 to 5 showed an equally excellent effect of suppressing NO and PGE 2 expression and were also excellent in suppressing inflammatory cytokine production.
관능성 평가Sensory evaluation
하기와 같이 실시예 조성물을 이용하여 통상적인 방법으로 보습 크림을 제조하였다. 이후 남녀 20명을 대상으로 향, 발림성 및 보습 효과에 대한 평가를 요청하였다. A moisturizing cream was prepared in a conventional manner using the example composition as follows. Afterwards, 20 men and women were asked to evaluate the scent, applicability, and moisturizing effect.
실시예 조성물 3.0 중량%Example composition 3.0% by weight
글리세린 8.0 중량%Glycerin 8.0% by weight
부틸렌글라이콜 5.0 중량%Butylene glycol 5.0% by weight
글리세릴스테아레이트/피이지-100스테아레이트 1.0 중량%Glyceryl stearate/PEG-100 stearate 1.0% by weight
폴리솔베이트60 0.5 중량%Polysorbate 60 0.5% by weight
소르비탄 스테아레이트 0.5 중량%Sorbitan stearate 0.5% by weight
피토스쿠알란 5.0 중량%Phytosqualane 5.0% by weight
호호바 오일 3.0 중량%Jojoba oil 3.0% by weight
카프릴/카프릭 트리글리세라이드 15.0 중량%Caprylic/capric triglyceride 15.0% by weight
알로에 버터 2.0 중량%Aloe butter 2.0% by weight
밀납 1.0 중량%Beeswax 1.0% by weight
스테아릴 알코올 0.5 중량%Stearyl alcohol 0.5% by weight
베헤릴 알코올 0.5 중량%Beheryl alcohol 0.5% by weight
스테아린산 0.5 중량%Stearic acid 0.5% by weight
카르복실비닐폴리머 0.2 중량%Carboxyl vinyl polymer 0.2% by weight
잔탄검 0.1 중량%Xanthan gum 0.1% by weight
아르기닌 0.5 중량%Arginine 0.5% by weight
디메치콘 0.5 중량%Dimethicone 0.5% by weight
베타글루칸 0.2 중량%Beta-glucan 0.2% by weight
방부제 0.5 중량%Preservative 0.5% by weight
정제수 잔량Purified water remaining
각 항목에 대한 평가는 10점 만점을 기준으로 평가를 요청하였으며, 평가 결과는 평균 값으로 도출하였다.The evaluation of each item was requested based on a 10-point scale, and the evaluation results were derived as the average value.
상기 실험 결과에 의하면, 실시예 3 내지 5에서 향, 발림성 및 보습성에서 우수한 평가를 받았으며, 종합적인 기호도에서도 우수한 평가를 받은 것을 확인하였다.According to the above experimental results, it was confirmed that Examples 3 to 5 received excellent evaluations in fragrance, spreadability, and moisturizing properties, and also received excellent evaluations in overall preference.
이상에서 본 발명의 바람직한 실시예에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.Although the preferred embodiments of the present invention have been described in detail above, the scope of the present invention is not limited thereto, and various modifications and improvements made by those skilled in the art using the basic concept of the present invention defined in the following claims are also possible. falls within the scope of rights.
Claims (7)
피부 안티폴루션용 조성물.Contains banana peel extract, marjoram extract, seaweed extract, and honeysuckle extract as active ingredients.
Composition for skin anti-pollution.
상기 바나나 껍질 추출물은 물, C1 내지 C6의 저급 알코올 및 이들의 혼합물로 이루어진 군으로부터 선택되는 추출 용매를 이용하여 추출되는 것인
피부 안티폴루션용 조성물.According to paragraph 1,
The banana peel extract is extracted using an extraction solvent selected from the group consisting of water, C 1 to C 6 lower alcohols, and mixtures thereof.
Composition for skin anti-pollution.
상기 조성물은 유해 인자로 인해 유도된 NO, PGE2 및 염증성 사이토카인 생성 억제 효과가 우수한
피부 안티폴루션용 조성물.According to paragraph 1,
The composition has an excellent effect of suppressing the production of NO, PGE 2 and inflammatory cytokines induced by harmful factors.
Composition for skin anti-pollution.
상기 유해 인자는 미세먼지, 다환 방향족 탄화수소, 알데하이드류, 질소산화물류 및 이들의 혼합으로 이루어진 군으로부터 선택되는
피부 안티폴루션용 조성물.According to paragraph 3,
The harmful factors are selected from the group consisting of fine dust, polycyclic aromatic hydrocarbons, aldehydes, nitrogen oxides, and mixtures thereof.
Composition for skin anti-pollution.
기능성 화장료 조성물.Comprising the composition for skin anti-pollution according to any one of claims 1 to 4.
Functional cosmetic composition.
기능성 식품 조성물.Comprising the composition for skin anti-pollution according to any one of claims 1 to 4.
Functional food composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210092445A KR102586050B1 (en) | 2021-07-14 | 2021-07-14 | Composition for skin anti-pollution containing banana peel extract as an active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210092445A KR102586050B1 (en) | 2021-07-14 | 2021-07-14 | Composition for skin anti-pollution containing banana peel extract as an active ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230011778A KR20230011778A (en) | 2023-01-25 |
KR102586050B1 true KR102586050B1 (en) | 2023-10-05 |
Family
ID=85109606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210092445A KR102586050B1 (en) | 2021-07-14 | 2021-07-14 | Composition for skin anti-pollution containing banana peel extract as an active ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102586050B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003095967A (en) * | 2001-09-27 | 2003-04-03 | Ichimaru Pharcos Co Ltd | Anti-allergic medicine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101873218B1 (en) * | 2016-07-29 | 2018-07-03 | 코스맥스 주식회사 | Composition for alleviating skin irritation and skin inflammation induced by particulate matter comprising extracts mixture of Ocimum sanctum, Mentha haplocalyx, and Azadirachta indica |
KR102255036B1 (en) | 2020-03-30 | 2021-05-21 | 국립낙동강생물자원관 | Antioxidant and skin anti-pollution composition containing evening primrose EXTRACT |
-
2021
- 2021-07-14 KR KR1020210092445A patent/KR102586050B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003095967A (en) * | 2001-09-27 | 2003-04-03 | Ichimaru Pharcos Co Ltd | Anti-allergic medicine |
Also Published As
Publication number | Publication date |
---|---|
KR20230011778A (en) | 2023-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100982883B1 (en) | Cosmetic composition comprising mixture extract and preparation thereof | |
WO2005105126A1 (en) | Active oxygen eliminator and moisturizer containing wild watermelon extract | |
KR101591872B1 (en) | Cosmetic composition with anti-inflammatory, anti-allergic and antioxidant effects containing Ge-8 extract mixture | |
JP2003192605A (en) | Lipase inhibitant | |
JP4658290B2 (en) | Fibroblast proliferating agent, cosmetic food and drink, and skin cosmetics | |
KR100899278B1 (en) | Cosmetic composition | |
JP2006063038A (en) | Antiaging composition, cosmetic containing the same, and food and drink containing the same | |
KR102561149B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR20220028612A (en) | Cosmetic composition antimicroboal, antioxidation, whitening or anti-inflammation comprising artemisia capillaris thunberg and olive extract | |
KR102586050B1 (en) | Composition for skin anti-pollution containing banana peel extract as an active ingredient | |
JP2005281205A (en) | Macrophage activator | |
JP6154606B2 (en) | Antioxidant or whitening cosmetic composition containing an extract of Korean medicine | |
JP2002302452A (en) | Histamine separation inhibitor, cyclic amp phosphodiesterase inhibitor, active oxygen scavenger and radical scavenger | |
KR101757457B1 (en) | Cosmetic composition containing natural complex extract for anti-thermal skin aging and skin soothing | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20170137436A (en) | Composition for improving skin condition comprising herb extracts mixture | |
JP3938693B2 (en) | Collagen production promoter, skin cosmetics and cosmetics | |
KR102503191B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR102589451B1 (en) | Anti-pollution composition containing schisandra chinensis extract | |
KR20240048978A (en) | Antioxidant, anti-inflammatory and skin soothing composition containing mung bean extract as an active ingredient | |
JP3935360B2 (en) | Hyaluronic acid production promoter, skin cosmetics and cosmetics | |
JP4261571B2 (en) | Collagen production promoter, skin cosmetics and cosmetics | |
JP3900977B2 (en) | Skin cosmetics and beauty food and drink | |
KR102214621B1 (en) | Functional food composition containing black kelp | |
JP7301347B2 (en) | Sirtuin 1 activator and skin cosmetic for sirtuin 1 activation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |